{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T02:21:58Z","timestamp":1782267718574,"version":"3.54.5"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bcp.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T08:00:29Z","timestamp":1500105629000},"page":"168-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Study of new interactions of glitazone\u2019s stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins"],"prefix":"10.1016","volume":"142","author":[{"given":"Samuel","family":"\u00c1lvarez-Almaz\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martiniano","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feliciano","family":"Tamay-Cach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlet","family":"Mart\u00ednez-Archundia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Alem\u00e1n-Gonz\u00e1lez-Duhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Correa-Basurto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Elena","family":"Mendieta-Wejebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2017.07.012_b0005","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.ejmech.2007.02.015","article-title":"Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hipolipidemic activities","volume":"42","author":"Da Costa","year":"2007","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11892-013-0378-8","article-title":"The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus","volume":"13","author":"Yau","year":"2013","journal-title":"Curr Diab Rep."},{"issue":"1","key":"10.1016\/j.bcp.2017.07.012_b0015","doi-asserted-by":"crossref","first-page":"e45638","DOI":"10.1371\/journal.pone.0045638","article-title":"Phytol\/Phytanic acid and insulin resistance: potential role of phytanic acid proven by Docking simulation and modulation of biochemical alterations","volume":"8","author":"Elmazar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2017.07.012_b0020","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpba.2007.09.004","article-title":"Investigation of racemisation of the enantiomers of glitazone drug compounds at different pH using chiral HPLC and chiral CE","volume":"46","author":"Jamali","year":"2008","journal-title":"J. Pharmaceut. Biomed."},{"key":"10.1016\/j.bcp.2017.07.012_b0025","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7614270","article-title":"Current advances in the biochemical and physiological aspects of the treatment of type 2 diabetes mellitus with thiazolidinediones","volume":"2016","author":"Alem\u00e1n-Gonz\u00e1lez-Duhart","year":"2016","journal-title":"PPAR Res."},{"key":"10.1016\/j.bcp.2017.07.012_b0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/B978-0-12-800101-1.00007-7","article-title":"The roles of peroxisome proliferator-activated receptors in the metabolic syndrome","volume":"121","author":"Mansour","year":"2014","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.bcp.2017.07.012_b0035","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.bbrc.2007.10.057","article-title":"Selective modulation of promoter recruitment and transcriptional activity of PPAR\u03b3\u0303","volume":"364","author":"Sears","year":"2007","journal-title":"Biochem. Biophys. Res. Co"},{"key":"10.1016\/j.bcp.2017.07.012_b0040","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JRS-2012-0559","article-title":"The rosiglitazone decision process at FDA and EMA What should we learn?","volume":"24","author":"Pouwelsa","year":"2012","journal-title":"Int. J. Risk Saf. Med."},{"key":"10.1016\/j.bcp.2017.07.012_b0045","unstructured":"Food and Drug Administration (FDA). FDA significantly restricts access to the diabetes drug Avandia. Postmarket Drug Safety Information for Patients and Providers 2010. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm226956.htm. Accessed Dec 1st, 2016."},{"key":"10.1016\/j.bcp.2017.07.012_b0050","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.taap.2009.07.021","article-title":"Troglitazone, but not rosiglitazone, damages mitochondrial DNA and induces mitochondrial dysfunction and cell death in human hepatocytes","volume":"240","author":"Rachek","year":"2009","journal-title":"Toxicol. Appl. Pharm."},{"key":"10.1016\/j.bcp.2017.07.012_b0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jsb.2015.07.006","article-title":"Different binding and recognition modes of GL479, a dual agonist of Peroxisome Proliferator-Activated Receptor \u03b1\u29f9\u03b3","volume":"191","author":"Dos Santos","year":"2015","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.bcp.2017.07.012_b0060","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/cbdd.12102","article-title":"Discovery of thiazolidine-2,4-dione\/biphenylcarbonitrile hybrid as dual PPAR alpha\/gamma modulator with antidiabetic effect: in vitro, in silico and in vivo approaches","volume":"81","author":"Hidalgo-Figueroa","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bcp.2017.07.012_b0065","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11010-011-0923-1","article-title":"Novel PPAR\u03b3 partial agonists with weak activity and no cytotoxicity; identified by a simple PPAR gamma ligand screening system","volume":"358","author":"Cho","year":"2011","journal-title":"Mol. Cell Biochem."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.012_b0070","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1248\/bpb.29.423","article-title":"Unique properties of coactivator recruitment caused by differential binding of FK614, an anti-diabetic agent, to peroxisome proliferator-activated receptor \u03b3","volume":"29","author":"Fujimura","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bcp.2017.07.012_b0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.07.012_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/816856","article-title":"Review of the structural and dynamic mechanisms of PPAR\u03b3 partial agonism","author":"Kroker","year":"2015","journal-title":"PPAR Res."},{"key":"10.1016\/j.bcp.2017.07.012_b0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.yrtph.2017.02.008","article-title":"In silico design, chemical synthesis and toxicological evaluation of 1,3-thiazolidine-2,4-dione derivatives as PPAR\u03b3 agonists","volume":"86","author":"Alem\u00e1n-Gonz\u00e1lez-Duhart","year":"2017","journal-title":"Reg. Tox. Pharm."},{"key":"10.1016\/j.bcp.2017.07.012_b0090","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.1073\/pnas.96.11.6102","article-title":"A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation","volume":"96","author":"Oberfield","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2017.07.012_b0095","doi-asserted-by":"crossref","first-page":"28169","DOI":"10.1074\/jbc.M111.332106","article-title":"GQ-16, a novel peroxisome proliferator-activated receptor (PPAR gamma) ligand, promotes insulin sensitization without weight gain","volume":"287","author":"Amato","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0100","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0969-2126(01)00634-7","article-title":"Structure of the PPARalpha and -gamma ligand binding domain in complex with AZ 242; ligand selectivity and agonist activation in the PPAR family","volume":"9","author":"Cronet","year":"2001","journal-title":"Structure"},{"key":"10.1016\/j.bcp.2017.07.012_b0105","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1097-2765(00)80448-7","article-title":"Asymmetry in the PPAR\u03b3\/RXR\u03b1 crystal structure reveals the molecular basis of heterodimerization among nuclear receptors","volume":"5","author":"Gampe","year":"2000","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.bcp.2017.07.012_b0110","doi-asserted-by":"crossref","first-page":"e36297","DOI":"10.1371\/journal.pone.0036297","article-title":"Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) \u03b3activators and pan-PPAR partial agonists","volume":"7","author":"Liberato","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bcp.2017.07.012_b0115","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.ejmech.2008.01.032","article-title":"Tryptophan-containing dipeptide derivatives as potent PPAR gamma antagonists: design, synthesis, biological evaluation, and molecular modeling","volume":"43","author":"Deng","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0120","series-title":"Discovery Studio Modeling Environment, Release 2017","author":"Dassault Syst\u00e8mes BIOVIA","year":"2016"},{"key":"10.1016\/j.bcp.2017.07.012_b0125","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Cheminform."},{"key":"10.1016\/j.bcp.2017.07.012_b0130","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2017.07.012_b0135","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J. Comput. Chem."},{"issue":"9","key":"10.1016\/j.bcp.2017.07.012_b0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0145","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bcp.2017.07.012_b0150","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1080\/00268977700102571","article-title":"Algorithms for macromolecular dynamics and constraint dynamics","volume":"34","author":"Van Gunsteren","year":"1977","journal-title":"J. Mol. Phys."},{"key":"10.1016\/j.bcp.2017.07.012_b0155","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald-an N. log(N) method forewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.bcp.2017.07.012_b0160","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular-dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.bcp.2017.07.012_b0165","unstructured":"Maestro, version 10.5. Schr\u00f6dinger, LLC; New York, NY, USA: 2016\u20131."},{"issue":"18","key":"10.1016\/j.bcp.2017.07.012_b0170","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1021\/jp973084f","article-title":"All-atom empirical potential for molecular modeling and dynamics Studies of proteins","volume":"102","author":"MacKerell","year":"1998","journal-title":"J. Phys. Chem. B"},{"issue":"5","key":"10.1016\/j.bcp.2017.07.012_b0175","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1063\/1.467468","article-title":"Constant pressure molecular dynamics algorithms","volume":"101","author":"Martyna","year":"1994","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.bcp.2017.07.012_b0180","first-page":"327","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Chem. Phys."},{"issue":"9","key":"10.1016\/j.bcp.2017.07.012_b0185","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1063\/1.1389854","article-title":"Optimized particle-mesh Ewald\/multiple-time step integration for molecular dynamics simulations","volume":"115","author":"Batcho","year":"2001","journal-title":"J. Chem. Phys."},{"issue":"14","key":"10.1016\/j.bcp.2017.07.012_b0190","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1002\/jcc.20482","article-title":"Software news and updates Carma: a molecular dynamics analysis program","volume":"27","author":"Glykos","year":"2006","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0195","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1021\/ct300418h","article-title":"MMPBSA.py: an efficient program for end-state free energy calculations","volume":"8","author":"Miller","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bcp.2017.07.012_b0200","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/jcc.10379","article-title":"Converging free energy estimates: MMPB(GB)SA studies on the protein-protein complex Ras-Raf","volume":"25","author":"Gohlke","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2017.07.012_b0205","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bcp.2017.07.012_b0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins"},{"issue":"5","key":"10.1016\/j.bcp.2017.07.012_b0215","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1021\/pr3000688","article-title":"Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models","volume":"11","author":"Hou","year":"2012","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bcp.2017.07.012_b0220","unstructured":"Gumbart JG, Luo D. HBonds Plugin, Version 1.2. Theoretical and Computational Biophysics group, NIH Center for Macromolecular Modeling and Bioinformatics, at the Beckman Institute, University of Illinois at Urbana-Champaign; 2015. http:\/\/www.ks.uiuc.edu\/Research\/vmd\/plugins\/hbonds\/. Accessed Dec 20, 2016."},{"key":"10.1016\/j.bcp.2017.07.012_b0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ejmech.2015.11.030","article-title":"Design and synthesis of novel Y-shaped barbituric acid derivatives as PPAR\u03b3activators","volume":"108","author":"Dixit","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0230","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature07413","article-title":"Structure of the intact PPAR-\u03b3\u2013RXR-\u03b1 nuclear receptor complex on DNA","volume":"456","author":"Chandra","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2017.07.012_b0235","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/7081_036","article-title":"In silico studies on PPAR\u03b3 agonistic heterocyclic systems","volume":"3","author":"Khanna","year":"2006","journal-title":"Top. Heterocycl. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2017.07.012_b0240","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0245","doi-asserted-by":"crossref","first-page":"8637","DOI":"10.1074\/jbc.M210910200","article-title":"Ligand and coactivator identity determines the requirement of the charge clamp for coactivation of the peroxisome proliferator-activated receptor \u03b3","volume":"278","author":"Wu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0250","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1677\/joe.0.1770207","volume":"177","author":"Wigren","year":"2003","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.bcp.2017.07.012_b0255","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/7081_021","article-title":"QSAR studies on thiazolidines: a biologically privileged scaffold","volume":"4","author":"Prabhakar","year":"2006","journal-title":"Top. Heterocycl. Chem."},{"key":"10.1016\/j.bcp.2017.07.012_b0260","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jchromb.2014.01.013","article-title":"Chiral liquid chromatography resolution and stereoselective pharmacokinetic study of pioglitazone enantiomers in rats","volume":"951\u2013952","author":"Du","year":"2014","journal-title":"J. Chromatogr. B"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217304896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295217304896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T11:04:32Z","timestamp":1602500672000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295217304896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":52,"alternative-id":["S0006295217304896"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2017.07.012","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of new interactions of glitazone\u2019s stereoisomers and the endogenous ligand 15d-PGJ2 on six different PPAR gamma proteins","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}